Summit Therapeutics

Pfizer
Biotech

Pfizer lays out its PD-1xVEGF bispecific research strategy

The first wave of Pfizer's clinical trials for its PD-1xVEGF bispecific includes a head-to-head phase 3 against Keytruda.
Angus Liu Nov 11, 2025 11:43am
Akeso
Favicon Fierce Pharma

Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC

Oct 19, 2025 10:45am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Editor's Corner—Summit must submit to Big Pharma, stat

Sep 10, 2025 2:50pm
Summit
Favicon Fierce Pharma

Summit's global PD-1xVEGF data show new promising OS trend

Sep 7, 2025 3:30am
Akeso
Favicon Fierce Pharma

Akeso, Summit's PD-1xVEGF drug meets OS goal for the first time

Aug 26, 2025 11:36am
Question
Favicon Fierce Pharma

Summit in high-stakes deal talks with AstraZeneca: Bloomberg

Jul 7, 2025 10:45am